GRI BIO INC (GRI) Stock Balance Sheet
USA - NASDAQ:GRI - US3622AW4030 - Common Stock
1.95 USD
+0.02 (+1.04%)
1.93 USD
-0.02 (-1.03%)
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 3.28M | 5.03M | 1.81M | 3.78M | 3.70M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 3.81M | |||
| Other Current Assets | 649.00K | 587.00K | 1.13M | 371.00K | 619.00K | |||
| Total Current Assets | 3.93M | 5.62M | 2.93M | 4.15M | 8.13M | |||
| Non-Current Assets | ||||||||
| PPE Net | 112.00K | 124.00K | 22.00K | N/A | 206.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | 0.00 | N/A | |||
| Total Non-Current Assets | 112.00K | 124.00K | 22.00K | 0.00 | 206.00K | |||
| TOTAL ASSETS | 4.04M | 5.74M | 2.96M | 4.15M | 8.34M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 97.00K | |||
| Accrued Expenses | 555.00K | 385.00K | 750.00K | 401.00K | 353.00K | |||
| Accounts Payable | 1.36M | 897.00K | 1.41M | 977.00K | 918.00K | |||
| Other Current Liabilities | 863.00K | 354.00K | 537.00K | 432.00K | 1.08M | |||
| Total Current Liabilities | 2.78M | 1.64M | 2.70M | 1.81M | 2.44M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 72.00K | |||
| Other Non-Current Liabilities | 58.00K | 71.00K | 0.00 | N/A | N/A | |||
| Total Non-Current Liabilities | 58.00K | 71.00K | 0.00 | 0.00 | 72.00K | |||
| TOTAL LIABILITIES | 2.84M | 1.71M | 2.70M | 1.81M | 2.52M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -42.79M | -39.74M | -31.53M | -28.93M | -21.90M | |||
| Additional Paid In Capital | 43.99M | 43.77M | 31.79M | 31.27M | 27.72M | |||
| Common Shares | 100.00 | 100.00 | 100.00 | 1.00K | 700.00 | |||
| Other Shareholders' Equity | -100.00 | -100.00 | -100.00 | 0.00 | -2.70K | |||
| Shares Outstanding | 525.40K | 525.50K | 2.90K | 300.00 | 100.00 | |||
| Tangible Book Value per Share | 2.29 | 7.67 | 0.40 | 36.48 | 179.57 | |||
| Total Shareholders' Equity | 1.21M | 4.03M | 259.00K | 2.34M | 5.82M | |||
| TOTAL LIABILITIES AND EQUITY | 4.04M | 5.74M | 2.96M | 4.15M | 8.34M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.01 | |||
| Current Ratio | 1.41 | 3.43 | 1.09 | 2.29 | 3.32 | |||
| Return On Assets (ROA) | -279.02% | -174.25% | -441.04% | -169.17% | -111.61% | |||
| Return On Equity (ROE) | -935.93% | -248.02% | -5033.59% | -299.91% | -159.90% | |||
All data in USD , ROIC based on taxRate of 0.21